Compile Data Set for Download or QSAR
Report error Found 32 Enz. Inhib. hit(s) with all data for entry = 50037969
TargetTyrosine-protein kinase JAK2(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50201514(2-(3H-imidazo[4,5-c]pyridin-3-yl)-N-methoxy-7-meth...)
Affinity DataIC50: 6nMAssay Description:Inhibition of JAK2 by kinase-Glo luminescent assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK2(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50201503((2-(3H-imidazo[4,5-c]pyridin-3-yl)-7-methyl-4-((S)...)
Affinity DataIC50: 11nMAssay Description:Inhibition of JAK2 by kinase-Glo luminescent assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK2(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193995(CP-690550 | 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrro...)
Affinity DataIC50: 11nMAssay Description:Inhibition of JAK2 by kinase-Glo luminescent assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK3(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50193995(CP-690550 | 3-((3R,4R)-4-methyl-3-(methyl(7H-pyrro...)
Affinity DataIC50: 13nMAssay Description:Inhibition of JAK3 by kinase-Glo luminescent assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK3(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50201514(2-(3H-imidazo[4,5-c]pyridin-3-yl)-N-methoxy-7-meth...)
Affinity DataIC50: 18nMAssay Description:Inhibition of JAK3 by kinase-Glo luminescent assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK2(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50201504(N-(2-(dimethylamino)ethyl)-2-(3H-imidazo[4,5-c]pyr...)
Affinity DataIC50: 19nMAssay Description:Inhibition of JAK2 by kinase-Glo luminescent assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK2(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50201512((2-(3H-imidazo[4,5-c]pyridin-3-yl)-7-methyl-4-((S)...)
Affinity DataIC50: 21nMAssay Description:Inhibition of JAK2 by kinase-Glo luminescent assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK3(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50201503((2-(3H-imidazo[4,5-c]pyridin-3-yl)-7-methyl-4-((S)...)
Affinity DataIC50: 22nMAssay Description:Inhibition of JAK3 by kinase-Glo luminescent assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK2(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50201516(2-(3H-imidazo[4,5-c]pyridin-3-yl)-N-(2-methoxyethy...)
Affinity DataIC50: 25nMAssay Description:Inhibition of JAK2 by kinase-Glo luminescent assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK3(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50201504(N-(2-(dimethylamino)ethyl)-2-(3H-imidazo[4,5-c]pyr...)
Affinity DataIC50: 34nMAssay Description:Inhibition of JAK3 by kinase-Glo luminescent assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK2(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50201502(2-(3H-imidazo[4,5-c]pyridin-3-yl)-7-methyl-N-(3-mo...)
Affinity DataIC50: 42nMAssay Description:Inhibition of JAK2 by kinase-Glo luminescent assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK3(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50201506(2-(3H-imidazo[4,5-c]pyridin-3-yl)-7-methyl-N-(meth...)
Affinity DataIC50: 42nMAssay Description:Inhibition of JAK3 by kinase-Glo luminescent assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK3(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50201502(2-(3H-imidazo[4,5-c]pyridin-3-yl)-7-methyl-N-(3-mo...)
Affinity DataIC50: 46nMAssay Description:Inhibition of JAK3 by kinase-Glo luminescent assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK3(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50201512((2-(3H-imidazo[4,5-c]pyridin-3-yl)-7-methyl-4-((S)...)
Affinity DataIC50: 49nMAssay Description:Inhibition of JAK3 by kinase-Glo luminescent assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK2(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50201517(N-(3-(1H-imidazol-1-yl)propyl)-2-(3H-imidazo[4,5-c...)
Affinity DataIC50: 53nMAssay Description:Inhibition of JAK2 by kinase-Glo luminescent assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK2(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50201506(2-(3H-imidazo[4,5-c]pyridin-3-yl)-7-methyl-N-(meth...)
Affinity DataIC50: 55nMAssay Description:Inhibition of JAK2 by kinase-Glo luminescent assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK3(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50201517(N-(3-(1H-imidazol-1-yl)propyl)-2-(3H-imidazo[4,5-c...)
Affinity DataIC50: 67nMAssay Description:Inhibition of JAK3 by kinase-Glo luminescent assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK3(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50201516(2-(3H-imidazo[4,5-c]pyridin-3-yl)-N-(2-methoxyethy...)
Affinity DataIC50: 77nMAssay Description:Inhibition of JAK3 by kinase-Glo luminescent assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK3(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50201509((2-(3H-imidazo[4,5-c]pyridin-3-yl)-4-((S)-1-methox...)
Affinity DataIC50: 126nMAssay Description:Inhibition of JAK3 by kinase-Glo luminescent assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK2(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50201510((4-(2-chloro-5-methoxyphenylamino)-2-(3H-imidazo[4...)
Affinity DataIC50: 132nMAssay Description:Inhibition of JAK2 by kinase-Glo luminescent assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK3(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50201507((4-((S)-3-hydroxy-3-methylbutan-2-ylamino)-2-(3H-i...)
Affinity DataIC50: 142nMAssay Description:Inhibition of JAK3 by kinase-Glo luminescent assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK3(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50201510((4-(2-chloro-5-methoxyphenylamino)-2-(3H-imidazo[4...)
Affinity DataIC50: 142nMAssay Description:Inhibition of JAK3 by kinase-Glo luminescent assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK3(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50201508(2-(3H-imidazo[4,5-c]pyridin-3-yl)-7-methyl-4-((S)-...)
Affinity DataIC50: 143nMAssay Description:Inhibition of JAK3 by kinase-Glo luminescent assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK3(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50201505((4-(tert-butylamino)-2-(3H-imidazo[4,5-c]pyridin-3...)
Affinity DataIC50: 200nMAssay Description:Inhibition of JAK3 by kinase-Glo luminescent assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK2(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50201507((4-((S)-3-hydroxy-3-methylbutan-2-ylamino)-2-(3H-i...)
Affinity DataIC50: 209nMAssay Description:Inhibition of JAK2 by kinase-Glo luminescent assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK2(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50201509((2-(3H-imidazo[4,5-c]pyridin-3-yl)-4-((S)-1-methox...)
Affinity DataIC50: 222nMAssay Description:Inhibition of JAK2 by kinase-Glo luminescent assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK2(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50201511((2-(3H-imidazo[4,5-c]pyridin-3-yl)-7-methyl-4-((R)...)
Affinity DataIC50: 298nMAssay Description:Inhibition of JAK2 by kinase-Glo luminescent assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK2(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50201505((4-(tert-butylamino)-2-(3H-imidazo[4,5-c]pyridin-3...)
Affinity DataIC50: 323nMAssay Description:Inhibition of JAK2 by kinase-Glo luminescent assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK2(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50201508(2-(3H-imidazo[4,5-c]pyridin-3-yl)-7-methyl-4-((S)-...)
Affinity DataIC50: 359nMAssay Description:Inhibition of JAK2 by kinase-Glo luminescent assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK3(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50201511((2-(3H-imidazo[4,5-c]pyridin-3-yl)-7-methyl-4-((R)...)
Affinity DataIC50: 430nMAssay Description:Inhibition of JAK3 by kinase-Glo luminescent assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK2(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50201513((4-(2-fluorobenzylamino)-2-(3H-imidazo[4,5-c]pyrid...)
Affinity DataIC50: 1.86E+3nMAssay Description:Inhibition of JAK2 by kinase-Glo luminescent assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2012
Entry Details Article
PubMed
TargetTyrosine-protein kinase JAK3(Human)
Procter and Gamble Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50201513((4-(2-fluorobenzylamino)-2-(3H-imidazo[4,5-c]pyrid...)
Affinity DataIC50: 3.05E+3nMAssay Description:Inhibition of JAK3 by kinase-Glo luminescent assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
12/11/2012
Entry Details Article
PubMed